Cell, tissue and gene therapy
Section edited by David Stroncek
This section aims to improve communication between basic and clinical research related to cell, tissue and gene therapies. Effective clinical therapies require efficient translation of research between the bench and bedside to allow the discovery, development, scale up, and production of cells, tissues and vectors. These therapies are being used to treat patients with a range of diseases including cancer, cardiovascular diseases, autoimmune disorders.
Studies considered for publication include those regarding the nature of cells, tissues and vectors used in clinical therapies; methods to collect, isolate and modify cells; and novel reagents, equipment, and instruments used in production. The section also welcomes research into the application of clinical therapies; factors that effect the safety and efficacy; in particular the potency, stability and purity of cells or tissue; and issues related to the safety of cell and tissue donors.
A therapeutic cancer vaccine against GL261 murine glioma
Mark S. Kindy, et al
Endothelium-targeted human Delta-like 1 enhances the regeneration and homing of human cord blood stem and progenitor cells
Deng-Mei Tian, Ying-Min Liang and Yong-Qing Zhang
Obesity inhibits the osteogenic differentiation of human adipose-derived stem cells
Amy L. Strong, et al
2017 Journal Metrics
56 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
104 days from submission to acceptance
10 days from acceptance to publication
2,714 Altmetric mentions